Protagonist Therapeutics, Inc SEC filings PTGX

Protagonist Therapeutics, Inc has 706 filings in SEC EDGAR's recent list, going back to Sep 28, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Protagonist Therapeutics, Inc SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Oct 2, 2026 Sep 30, 2026
144 Notice of proposed sale Sep 30, 2026 —
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
4 Insider transaction Aug 12, 2026 Aug 10, 2026
144 Notice of proposed sale Aug 10, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 POS Filing Aug 5, 2026 —
S-8 Employee stock plan registration Aug 5, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
144 Notice of proposed sale Jun 23, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
144 Notice of proposed sale Jun 10, 2026 —
4 Insider transaction Jun 1, 2026 May 29, 2026
144 Notice of proposed sale May 29, 2026 —
4/A Ownership document May 14, 2026 May 12, 2026
4 Insider transaction May 12, 2026 May 12, 2026
144 Notice of proposed sale May 12, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 12, 2026 —
4 Insider transaction May 11, 2026 May 7, 2026
144 Notice of proposed sale May 8, 2026 —
144 Notice of proposed sale May 7, 2026 —
144 Notice of proposed sale May 7, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 17, 2026
4 Insider transaction Apr 24, 2026 Apr 23, 2026
4 Insider transaction Apr 21, 2026 Apr 20, 2026
144 Notice of proposed sale Apr 21, 2026 —
4 Insider transaction Mar 27, 2026 Mar 26, 2026
4 Insider transaction Mar 27, 2026 Mar 26, 2026
4 Insider transaction Mar 27, 2026 Mar 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
144 Notice of proposed sale Mar 26, 2026 —
144 Notice of proposed sale Mar 26, 2026 —
144 Notice of proposed sale Mar 26, 2026 —
4 Insider transaction Mar 25, 2026 Mar 23, 2026
144 Notice of proposed sale Mar 24, 2026 —
S-8 Employee stock plan registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
144 Notice of proposed sale Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2026 —
4 Insider transaction Feb 6, 2026 Feb 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2026 —
144 Notice of proposed sale Feb 6, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2026 —
4 Insider transaction Jan 27, 2026 Jan 23, 2026
4 Insider transaction Jan 27, 2026 Jan 27, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2026
144 Notice of proposed sale Jan 27, 2026 —
144 Notice of proposed sale Jan 27, 2026 —
144 Notice of proposed sale Jan 26, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
4 Insider transaction Jan 21, 2026 Jan 20, 2026
4 Insider transaction Jan 21, 2026 Jan 20, 2026
4 Insider transaction Jan 21, 2026 Jan 20, 2026
144 Notice of proposed sale Jan 21, 2026 —
144 Notice of proposed sale Jan 21, 2026 —
144 Notice of proposed sale Jan 21, 2026 —
4 Insider transaction Jan 13, 2026 Jan 9, 2026
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Nov 24, 2025 Nov 21, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
4 Insider transaction Oct 14, 2025 Oct 10, 2025
144 Notice of proposed sale Oct 10, 2025 —
4 Insider transaction Sep 24, 2025 Sep 22, 2025
144 Notice of proposed sale Sep 22, 2025 —
4 Insider transaction Sep 18, 2025 Sep 16, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
144 Notice of proposed sale Aug 27, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 11, 2025 —
S-3ASR Automatic shelf registration Aug 6, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
4 Insider transaction Jul 28, 2025 Jul 25, 2025
4 Insider transaction Jul 23, 2025 Jul 21, 2025
144 Notice of proposed sale Jul 22, 2025 —
4 Insider transaction Jul 18, 2025 Jul 16, 2025
8-K Current report
Shareholder vote results
Jun 26, 2025 Jun 20, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Jun 16, 2025 —
4 Insider transaction Jun 11, 2025 Jun 9, 2025
144 Notice of proposed sale Jun 10, 2025 —
144 Notice of proposed sale Jun 9, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 13, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
4 Insider transaction Apr 30, 2025 Apr 28, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 29, 2025 —
4 Insider transaction Apr 23, 2025 Apr 22, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 10, 2025 —
8-K Current report
Other events
Mar 20, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
144 Notice of proposed sale Mar 17, 2025 —
4 Insider transaction Mar 14, 2025 Mar 13, 2025
4 Insider transaction Mar 14, 2025 Mar 12, 2025
144 Notice of proposed sale Mar 13, 2025 —
144 Notice of proposed sale Mar 12, 2025 —
8-K/A Amended current report
Other events
Mar 11, 2025 Mar 8, 2025
8-K Current report
Other events
Mar 10, 2025 Mar 8, 2025
4 Insider transaction Mar 5, 2025 Mar 5, 2025
8-K Current report
Other events
Mar 3, 2025 Mar 3, 2025
S-8 Employee stock plan registration Feb 21, 2025 —
10-K Annual report Feb 21, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 21, 2025 Feb 21, 2025
4 Insider transaction Feb 20, 2025 Feb 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2025 —
4 Insider transaction Jan 17, 2025 Jan 16, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 16, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
8-K Current report
Officer or director change
Jan 6, 2025 Jan 1, 2025
4 Insider transaction Nov 27, 2024 Nov 26, 2024
4 Insider transaction Nov 27, 2024 Nov 25, 2024
4 Insider transaction Nov 27, 2024 Nov 25, 2024
144 Notice of proposed sale Nov 27, 2024 —
144 Notice of proposed sale Nov 26, 2024 —
144 Notice of proposed sale Nov 26, 2024 —
144 Notice of proposed sale Nov 25, 2024 —
144 Notice of proposed sale Nov 25, 2024 —
4 Insider transaction Nov 21, 2024 Nov 19, 2024
4 Insider transaction Nov 19, 2024 Nov 15, 2024
8-K Current report
Material agreement, Other events
Nov 18, 2024 Nov 13, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
SC 13G Ownership over 5% (passive) Oct 16, 2024 —
8-K Current report
Officer or director change
Sep 20, 2024 Sep 17, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 10, 2024
144 Notice of proposed sale Sep 11, 2024 —
144 Notice of proposed sale Sep 10, 2024 —
SC 13G/A Amended ownership over 5% (passive) Aug 7, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jul 26, 2024 Jul 24, 2024
144 Notice of proposed sale Jul 24, 2024 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 26, 2024 Jun 20, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
144 Notice of proposed sale Jun 7, 2024 —
144 Notice of proposed sale Jun 7, 2024 —
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 20, 2024
4 Insider transaction Apr 19, 2024 Apr 18, 2024
PRE 14A Preliminary proxy statement Apr 12, 2024 Jun 20, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTGX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Newark, CA
SEC filer status
Large accelerated filer
SEC CIK
1377121
Former names
Protagonist Therapeutics Inc (until Jun 11, 2013); Protagonist Inc (until Sep 28, 2006)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.